Leading Manufacturer, Supplier and Exporter of Glipizide ER 10mg Tablets (Gluvi) PAN India

Taj Pharma India is one of the most trusted pharmaceutical manufacturers and exporters in India, recognized for producing high-quality Glipizide ER 10mg Tablets (Gluvi) that meet global standards of purity, efficacy, and safety. With a strong foundation in Vapi, Gujarat, Taj Pharma stands at the forefront of innovative diabetes management solutions, catering to domestic and international markets with precision and care.


About Glipizide ER 10mg Tablets (Gluvi)

Glipizide ER Tablets (Gluvi) are an extended-release oral formulation designed for the management of type 2 diabetes mellitus. This medication works by stimulating the pancreas to release insulin, effectively lowering blood glucose levels and maintaining glycemic control. The extended-release technology ensures steady drug absorption, reducing the frequency of dosage and minimizing fluctuations in blood sugar levels throughout the day.

Taj Pharma’s Glipizide ER 10mg Tablets are widely trusted by healthcare professionals for their reliable performance, superior quality, and patient-friendly formulation.


Trusted Glipizide ER Tablets Manufacturer in India

As one of the top Glipizide ER Tablets manufacturers in India, Taj Pharma India combines scientific innovation with world-class manufacturing standards to produce medicines that enhance patient outcomes. Our manufacturing units are WHO-GMP and ISO 9001:2015 certified, reflecting our dedication to quality assurance, precision, and global regulatory compliance.

Each batch of Glipizide ER Tablets is carefully formulated using pharma-grade raw materials and undergoes rigorous quality control testing to ensure purity, stability, and therapeutic effectiveness.


Key Benefits of Glipizide ER Tablets (Gluvi)

  • Effective blood sugar control: Helps regulate glucose levels by increasing natural insulin secretion.
  • Extended-release action: Ensures a gradual release for sustained effect throughout the day.
  • Once-daily dosage: Enhances patient convenience and compliance.
  • High bioavailability: Provides consistent therapeutic results.
  • Globally approved standards: Manufactured under strict WHO-GMP guidelines for safety and efficacy.

Therapeutic Uses and Indications

Glipizide ER Tablets are primarily prescribed for the treatment of type 2 diabetes mellitus in adults. It is used along with a balanced diet and regular exercise to improve glycemic control. The medication may also be used in combination with other oral antidiabetic agents or insulin for better results under medical supervision.


Dosage and Administration Guidelines

  • Recommended Dose: The usual starting dose is 5 mg to 10 mg once daily, adjusted according to individual response.
  • Administration: Take Glipizide ER Tablets shortly before or with breakfast for optimal absorption.
  • Missed Dose: Skip the missed dose if it’s almost time for your next scheduled dose. Do not double the dosage.
  • Precaution: Avoid skipping meals or consuming alcohol while on this medication, as it may cause hypoglycemia (low blood sugar).

Precautions and Safety Advice

  • Hypoglycemia Risk: Monitor for symptoms like dizziness, sweating, or confusion, especially when used with other antidiabetic agents.
  • Liver Function: Regular liver function tests are recommended during long-term therapy.
  • Driving & Machinery: Use caution when operating heavy machinery or driving until the effect of the drug is known.
  • Pregnancy and Lactation: Use only under the guidance of a qualified healthcare professional.

Taj Pharma’s Manufacturing Excellence

Taj Pharma India maintains state-of-the-art pharmaceutical manufacturing units in Vapi, Gujarat, equipped with advanced machinery, cleanroom technology, and automated quality assurance systems. Every stage—from formulation to packaging—follows stringent quality protocols aligned with WHO, USFDA, and EMA guidelines.

Our Key Strengths

  • WHO-GMP & ISO-certified facilities
  • In-house quality assurance and microbiological testing laboratories
  • Experienced R&D team for continuous innovation
  • Regulatory documentation support (COA, COPP, CTD Dossiers)
  • Environmentally sustainable and ethical manufacturing practices

Glipizide ER Tablets Packaging and Specifications

ParameterDetails
Brand NameGluvi
Dosage FormExtended Release Tablets
Strength10mg
Packaging TypeBlister or Bottle Packaging
Pack SizeCustomized as per market requirement
Shelf Life24 to 36 months
StorageStore below 30°C in a dry, cool place

Each tablet is tested for uniformity, dissolution, and stability, ensuring a long shelf life and therapeutic reliability.


Glipizide ER Tablets Export and Global Reach

Taj Pharma India has established a strong export network across Africa, the Middle East, Latin America, and Southeast Asia, offering regulatory-compliant pharmaceutical products to a growing number of countries. Our Glipizide ER Tablets (Gluvi) are recognized globally for superior formulation quality, affordability, and effectiveness.

We provide comprehensive export documentation, including:

  • COA (Certificate of Analysis)
  • COPP (Certificate of Pharmaceutical Product)
  • CTD Dossier
  • Stability Data

Our global supply chain efficiency ensures on-time delivery and consistent product availability to healthcare providers worldwide.


PCD Pharma Franchise for Glipizide ER Tablets (Gluvi)

Taj Pharma India invites partners for PCD Pharma Franchise opportunities across PAN India. We provide an excellent platform for distributors, wholesalers, and medical representatives to grow their pharmaceutical business with our trusted brand portfolio.

Franchise Benefits

  • Monopoly marketing rights in assigned territories
  • Attractive profit margins and incentives
  • Promotional materials support (visual aids, product samples, literature)
  • Fast delivery and consistent product availability

Our PCD Pharma Franchise model is designed to promote long-term business success through mutual trust and profitability.


Third-Party Manufacturing Services

Taj Pharma India also specializes in contract and third-party manufacturing for Glipizide ER Tablets. We partner with pharma companies, startups, and healthcare institutions looking for high-quality production solutions at competitive rates.

Our end-to-end third-party manufacturing services include:

  • Product development and formulation
  • Regulatory and technical documentation
  • Packaging design and private labeling
  • Quality control and testing
  • Logistics and timely delivery

With years of experience in pharmaceutical contract manufacturing, Taj Pharma ensures seamless production and regulatory compliance for every partner.


Why Choose Taj Pharma India?

  • Leading Glipizide ER Tablets Manufacturer in India
  • WHO-GMP and ISO 9001:2015 Certified
  • Trusted by Healthcare Professionals Globally
  • Strong Export Presence Across Continents
  • Competitive Pricing with Assured Quality
  • Dedicated Regulatory and Technical Support Team

Commitment to Quality and Innovation

At Taj Pharma India, we believe that quality healthcare should be accessible to all. Our commitment to innovation, research, and affordability drives our success in the antidiabetic pharmaceutical market. Every Glipizide ER Tablet (Gluvi) we produce reflects our dedication to excellence, patient safety, and long-term health outcomes.


Taj Pharma India continues to set benchmarks as a leading manufacturer, supplier, and exporter of Glipizide ER 10mg Tablets (Gluvi) in India. With a strong foundation in pharmaceutical innovation, regulatory expertise, and global partnerships, we are proud to deliver affordable and reliable diabetic care solutions worldwide.

For distributors, importers, and healthcare professionals, partnering with Taj Pharma India guarantees trust, quality, and growth—making us your ideal choice for Glipizide ER Tablets manufacturing and supply in India.